BGGS
OACCW

Boussard & Gavaudan Gestion SAS’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Boussard & Gavaudan Gestion SAS’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Buy
+150,000
New +$126K 0.01% 88

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Boussard & Gavaudan Gestion SAS's OACCW Position: Q2 2026 in Review

Boussard & Gavaudan Gestion SAS opened a new position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q2 2026: 150,000 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #88 among its holdings.

27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

  • Boussard & Gavaudan Gestion SAS held 150,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $134K as of Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant was a new Boussard & Gavaudan Gestion SAS position in Q2 2026.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up 0.01% of Boussard & Gavaudan Gestion SAS's portfolio in Q2 2026, its #88 holding.
  • 27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Boussard & Gavaudan Gestion SAS's 13F filing for Q2 2026, filed 19 Aug 2026.